The 2013 China 20 Top firms in II’s China 20 reap big asset gains as regulators allow a proliferation of new product offerings. September 30, 2013 Related Articles Premium Hedge Funds Miss 2025’s Biggest Stock Surges Stephen Taub Premium Biopharma Specialist Cormorant Plans New $125 Million Blank-Check Venture Stephen Taub Podcast- Managed Futures: Systematically Following the Trend Until it Bends Sponsored by Fidelity Investments